期刊文献+

骨质疏松症的药物治疗 被引量:2

The drug treatment of Osteoporosis
下载PDF
导出
摘要 骨质疏松症可分为原发性、继发性和特发性三大类,其中原发性骨质疏松是自然衰老过程中人体组织器官系统退行性改变在骨骼系统出现的症状,包括妇女绝经后骨质疏松和老年性骨质疏松,前者主要与绝经后雌激素不足有关;后者主要与增龄衰老有关。继发性骨质疏松是由于疾病或药物损害骨代谢所诱发的。特发性骨质疏松是发生于儿童,青少年和成人期的不明原因的骨质疏松。文中主要阐述原发性骨质疏松症的药物治疗。 Osteoporosis can be divided into primary, secondary and idiopathic three categories, including primary osteoporosis is a natural aging process of human tissue and organ systems degenerative changes in the skeletal system symptoms, including women postmenopausal osteoporosis and senile osteoporosis, the former mainly postmenopausal estrogen deficiency related; latter mainly relat- ed to aging with increasing age. Secondary osteoporosis is due to illness or drug - induced damage to bone metabolism. Idiopathic oste- oporosis occurs in children, adolescents and adults of unexplained osteoporosis. This article focuses on primary osteoporosis medica- tion.
作者 刘荣 赵柄康
出处 《中国民族民间医药》 2014年第7期58-60,共3页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 骨质疏松症 药物治疗 研究进展 Osteoporosis The drug treatment
  • 相关文献

参考文献18

  • 1何伟涛,刘康,孙金谞,史晓林.组织蛋白酶k与骨质疏松症治疗的研究进展[J].中国骨质疏松杂志,2008,14(9):670-673. 被引量:14
  • 2王世才,兰水中,林莉萍.常见病专家经典处方[M].北京:人民军医出版,2009:144.
  • 3DaviesGC, Huster WJ, Plouffe L , et al. Adverse events reported, by post- menopausal women in controlled trials with raloxifene [ J ]. J Obster Gynecol , 1999 , 93: 558.
  • 4Stoch SA . Zajic S , Stone J , et al. Effect of the cathepsin K inhibitor odan- acatib on bone resorption biomarkers in healthy postmen opausal women: two double -blind , randomized , placebocontrolled phase I studies. Clin Pharmacol Ther ,2009, 86: 175-182.
  • 5Archer DF , Pinkerton JV , Utian WH , et al. Bazedoxifene , a selective os- troger receptor modulator: effects on the endometrium , ovaries , and breast from a randomized controlled trial in osteoporotic postmenopausal women . Menopause , 2009 , 16 : 1109-1115.
  • 6陈援越,史晓林,刘建芳,廖筱美.雌孕激素联合阿仑膦酸钠治疗围绝经期骨量减少[J].中国骨质疏松杂志,2008,14(7):508-511. 被引量:2
  • 7杨铸,唐德志,杨洲,杨锋,卞琴,王拥军.药物治疗骨质疏松症的最新研究进展[J].中国中医骨伤科杂志,2011,19(12):70-72. 被引量:14
  • 8Gennari C . Analgesic effect of calcitonin in osteopom- sis [J ]. Bone , 2002 , 305: 67.
  • 9刘俊丽,张建中,施生根.重组骨保护素(rhOPG)药物的研究现状及应用展望[J].中国骨质疏松杂志,2008,14(1):65-67. 被引量:4
  • 10Daddona PE , Matriano JA , Mandema J , et al. Parathy roidhormone ( 1 - 34) -coated mieroneedle path system : clinical pharmacokineties and phamlaeo- dynamics for treatment of osteoporosis . Phaml Res , 2011 , 28 ( 1 ) : 159 - 165.

二级参考文献135

共引文献149

同被引文献16

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部